82W Stock Overview
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Hims & Hers Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.15 |
| 52 Week High | US$15.60 |
| 52 Week Low | US$5.36 |
| Beta | 0.91 |
| 1 Month Change | -15.85% |
| 3 Month Change | 41.50% |
| 1 Year Change | 1.83% |
| 3 Year Change | 29.35% |
| 5 Year Change | n/a |
| Change since IPO | -9.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| 82W | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -3.8% | 1.8% | -1.0% |
| 1Y | 1.8% | 1.8% | 2.2% |
Return vs Industry: 82W matched the German Healthcare industry which returned 2% over the past year.
Return vs Market: 82W matched the German Market which returned 2% over the past year.
Price Volatility
| 82W volatility | |
|---|---|
| 82W Average Weekly Movement | 14.0% |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 82W's share price has been volatile over the past 3 months.
Volatility Over Time: 82W's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,046 | Andrew Dudum | www.forhims.com |
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care.
Hims & Hers Health, Inc. Fundamentals Summary
| 82W fundamental statistics | |
|---|---|
| Market cap | €2.25b |
| Earnings (TTM) | -€21.87m |
| Revenue (TTM) | €810.00m |
2.8x
P/S Ratio-102.6x
P/E RatioIs 82W overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 82W income statement (TTM) | |
|---|---|
| Revenue | US$872.00m |
| Cost of Revenue | US$157.05m |
| Gross Profit | US$714.95m |
| Other Expenses | US$738.50m |
| Earnings | -US$23.55m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 06, 2024
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 81.99% |
| Net Profit Margin | -2.70% |
| Debt/Equity Ratio | 0% |
How did 82W perform over the long term?
See historical performance and comparison